Loading...
Loading...
WILMINGTON, Del., June 27, 2024 (GLOBE NEWSWIRE) -- The Akkermansia Company , creator of clinically proven, next-generation gut health solutions, is pleased to announce its launch into the U.S.
consumer market. The company's founders were the first to discover and decode Akkermansia muciniphila , the bacterium responsible for protecting the gut barrier to support optimal health and longevity. Akkermansia muciniphila exists naturally in a healthy gut, but many people have low levels, which can lead to a leaky gut and inflammation, linked to obesity, diabetes, cardiovascular disease, and other health challenges.
To solve this problem, The Akkermansia Company has developed dietary supplements with science-backed ingredients that replenish low levels of Akkermansia muciniphila and protect and restore the gut barrier. The supplements were many years of research in the making. In 2004, Professor Willem M.
de Vos, co-founder of The Akkermansia Company, and his team at Wageningen University were the first to discover Akkermansia muciniphila . Under the guidance of Professor de Vos, Dr. Muriel Derrien, a PhD student, successfully isolated and characterized Akkermansia muciniphila , and the team named the strain in honor of Dr.
Anton Akkermans, a famous microbial ecologist working in their Wageningen lab. Professor de Vos's team then developed pasteurized Akkermansia muciniphila MucTTM, the only strain of Akkermansia that has been clinically studied in humans. A 2.
